Reply to the letter to the editor 'Can ovarian suppression with gonadotropin releasing hormone analogs (GnRHa) preserve fertility in cancer patients?' by Rodriguez-Wallberg et al

Ann Oncol. 2016 Mar;27(3):548-9. doi: 10.1093/annonc/mdv599. Epub 2015 Dec 8.

Authors

M Lambertini¹, F A Peccatori², H C F Moore³, L Del Mastro⁴

Affiliations

¹ Deapartment of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genova.
² Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy.
³ Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, USA.
⁴ Deapartment of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genova, Italy [email protected].

PMID: 26646756
DOI: 10.1093/annonc/mdv599

No abstract available

Publication types

Letter
Comment

MeSH terms

Fertility
Gonadotropin-Releasing Hormone*
Humans
Neoplasms
Ovary*

Substances

Gonadotropin-Releasing Hormone